We are live on
!
Find out more
WG
Winton Group Portfolio holdings
AUM
$3.09B
1-Year Est. Return
40.4%
This Fund
S&P 500
This Quarter
Est. Return
+7.77%
1 Year Est. Return
+40.4%
3 Year Est. Return
+127.75%
5 Year Est. Return
+204.31%
10 Year Est. Return
+963.71%
AUM
$1.86B
AUM Growth
+$110M
(+6.3%)
Cap. Flow
+$8.27M
Cap. Flow
% of AUM
0.44%
Top 10 Holdings %
Top 10 Hldgs %
17.94%
Holding
1,569
New
208
Increased
710
Reduced
482
Closed
160
Avg Time Held
5.2
quarters
Top 10 Avg Time Held
1.5
quarters
Top 20 Avg Time Held
1.3
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$15M |
| 2 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$12.8M |
| 3 |
CSX Corp
CSX
|
+$11.6M |
| 4 |
NVIDIA
NVDA
|
+$10.5M |
| 5 |
State Street Utilities Select Sector SPDR ETF
XLU
|
+$9.02M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$34.4M |
| 2 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$28.2M |
| 3 |
iShares MBS ETF
MBB
|
+$24.1M |
| 4 |
State Street Communication Services Select Sector SPDR ETF
XLC
|
+$14.7M |
| 5 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$12.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 17.25% |
| 2 | Miscellaneous | 12.9% |
| 3 | Technology | 11.81% |
| 4 | Consumer Discretionary | 10.76% |
| 5 | Healthcare | 10.66% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1376
DELISTED
PlayAGS
AGS
| $123K | 0.01% |
12,473
-10,391
| -45% | -$95.9K |
2019 Q3
7 quarters
|
|
1377
DELISTED
Enzo Biochem, Inc.
ENZ
| $120K | 0.01% |
37,878
-428
| -1% | -$1.35K |
2019 Q3
7 quarters
|
|
1378
AIM ImmunoTech
AIM
$7.18M
| $118K | 0.01% |
+549
| New | +$118K |
2021 Q2
0 quarters
|
|
1379
iBio
IBIO
$56M
| $117K | 0.01% |
155
-53
| -25% | -$38.7K |
2020 Q2
4 quarters
|
|
1380
Reading International Class A
RDI
$43.3M
| $114K | 0.01% |
16,345
-2,223
| -12% | -$14.1K |
2019 Q3
7 quarters
|
|
1381
Lincoln Educational Services
LINC
$745M
| $111K | 0.01% |
+14,318
| New | +$102K |
2021 Q2
0 quarters
|
|
1382
DELISTED
Trevena, Inc.
TRVN
| $106K | 0.01% |
100
+6
| +6% | +$6.73K |
2019 Q3
7 quarters
|
|
1383
INNOVATE Corp
VATE
$98.5M
| $105K | 0.01% |
2,638
-575
| -18% | -$23.3K |
2019 Q4
6 quarters
|
|
1384
DELISTED
Carrols Restaurant Group, Inc.
TAST
| $105K | 0.01% |
17,542
-5,720
| -25% | -$33.8K |
2020 Q1
5 quarters
|
|
|
PAE
1385
DELISTED
PAE Incorporated Class A Common Stock
PAE
| $100K | 0.01% |
+11,190
| New | +$96.2K |
2021 Q2
0 quarters
|
|
|
STSA
1386
DELISTED
Satsuma Pharmaceuticals, Inc. Common Stock
STSA
| $98K | 0.01% |
13,955
-2,838
| -17% | -$15.3K |
2020 Q4
2 quarters
|
|
1387
Nokia
NOK
$58B
| $95K | 0.01% |
17,910
-20,663
| -54% | -$99.7K |
2020 Q4
2 quarters
|
|
1388
Acco Brands
ACCO
$414M
| $90K | ﹤0.01% |
10,465
-5,945
| -36% | -$52.8K |
2020 Q4
2 quarters
|
|
1389
Lite Strategy Inc
LITS
$38.6M
| $88K | ﹤0.01% |
1,543
+237
| +18% | +$15.2K |
2019 Q3
7 quarters
|
|
1390
KALA BIO
KALA
$5.68M
| $83K | ﹤0.01% |
6
-6
| -50% | -$94.3K |
2021 Q1
1 quarter
|
|
1391
Ramaco Resources Class A
METC
$554M
| $77K | ﹤0.01% |
14,479
-2,459
| -15% | -$11.7K |
2020 Q2
4 quarters
|
|
1392
DELISTED
Emerald Holding
EEX
| $76K | ﹤0.01% |
14,156
-8,847
| -38% | -$47.4K |
2019 Q3
7 quarters
|
|
1393
Voyager Therapeutics
VYGR
$151M
| $75K | ﹤0.01% |
+18,227
| New | +$82.6K |
2021 Q2
0 quarters
|
|
1394
Universal Technical Institute
UTI
$1.14B
| $72K | ﹤0.01% |
11,133
+84
| +0.8% | +$496 |
2020 Q4
2 quarters
|
|
1395
Amneal Pharmaceuticals
AMRX
$6.93B
| $69K | ﹤0.01% |
13,492
+956
| +8% | +$5.43K |
2021 Q1
1 quarter
|
|
1396
Pulmatrix
PULM
$5.33M
| $60K | ﹤0.01% |
2,887
+370
| +15% | +$7.49K |
2020 Q3
3 quarters
|
|
1397
cbdMD
YCBD
$4.37M
| $58K | ﹤0.01% |
56
-3
| -5% | -$3.59K |
2020 Q3
3 quarters
|
|
1398
DELISTED
PHX Minerals
PHX
| $57K | ﹤0.01% |
15,229
-2,374
| -13% | -$7.21K |
2019 Q3
7 quarters
|
|
1399
DELISTED
Assertio
ASRT
| $53K | ﹤0.01% |
2,263
-406
| -15% | -$11.7K |
2019 Q4
6 quarters
|
|
|
CNCE
1400
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
| $53K | ﹤0.01% |
12,648
+549
| +5% | +$2.32K |
2021 Q1
1 quarter
|
|
Similar funds
ZIC
SP
ACM
TE
PCM
SAM
DMIC
HC
Winton Group's Q2 2021 Portfolio in Review
As of Q2 2021, Winton Group held 1,569 positions worth $1.86B, up 6.3% from $1.75B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Winton Group's Q2 2021 filing shows 208 new, 710 increased, 482 reduced and 160 closed positions. Its largest new stake was State Street Consumer Staples Select Sector SPDR ETF: 213,654 shares worth $14.9M. The largest sale was State Street Financial Select Sector SPDR ETF, an estimated $34.4M.
By sector, the portfolio is most concentrated in Financials at 17% of assets, up from 16% a quarter earlier, followed by Miscellaneous and Technology.
- Winton Group's largest Q2 2021 buy was State Street Consumer Staples Select Sector SPDR ETF: 213,654 shares worth $14.9M.
- Winton Group added most to State Street Energy Select Sector SPDR ETF in Q2 2021, an estimated $12.8M increase.
- Winton Group's biggest Q2 2021 reduction was State Street Financial Select Sector SPDR ETF, cutting an estimated $34.4M.
- Winton Group fully exited State Street Technology Select Sector SPDR ETF in Q2 2021, selling an estimated $12.9M.
- Winton Group's ten largest holdings make up 18% of its $1.86B portfolio in Q2 2021.
- Winton Group opened 208 new positions and closed 160 in Q2 2021.
- Winton Group's portfolio value rose 6.3% quarter-over-quarter to $1.86B.
Based on Winton Group's 13F filing for Q2 2021, filed 10 Aug 2021.